


Ajinomoto Bio-Pharma Services Revenue
Pharmaceutical Manufacturing • 15-1, Kyobashi 1-chome, Japan • 501-1000 Employees
Ajinomoto Bio-Pharma Services revenue & valuation
| Annual revenue | $405,100,000 |
| Revenue per employee | $666,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $1,296,400,000 |
| Total funding | No funding |
Key Contacts at Ajinomoto Bio-Pharma Services
V Raju
Chief Executive Officer
Eric De Vos
Vp Of Global Innovation & Director Of R&D Europe
Amanda Jenson
Director Of Business Development
Bjorn Belpaeme
Director Supply Chain And Project Management
Dave Andrews
Us Sales Director
Eric Gudorf
Associate Director Of Commercial Operations
Christina Espinosa
Sr Director Drug Product Manufacturing - Visual Inspection, Terminal Sterilization, Packaging
Isaiahg Valdez
Director Of Operations
Tina Spannos
Director Of Finance
Jason Steele
Director Of Business Development
Company overview
| Headquarters | 15-1, Kyobashi 1-chome, Chuo-ku, Tokyo 104-8315, JP |
| Phone number | +813293653333 |
| Website | |
| NAICS | 3254 |
| SIC | 807 |
| Employees | 501-1000 |
| Socials |
Ajinomoto Bio-Pharma Services Email Formats
Ajinomoto Bio-Pharma Services uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 56.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 56.2% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 18.4% |
{last name}.{first name}@company.com | doe.john@company.com | 12.1% |
{first name}@company.com | john@company.com | 8.2% |
{first name}_{last name}@company.com | john_doe@company.com | 5.1% |
About Ajinomoto Bio-Pharma Services
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India, providing support across gene therapy, APIs, and both large and small molecule manufacturing. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our client’s needs. Learn more: www.AjiBio-Pharma.com
Employees by Management Level
Total employees: 501-1000
Seniority
Employees
Employees by Department
Ajinomoto Bio-Pharma Services has 269 employees across 14 departments.
Departments
Number of employees
Funding Data
Ajinomoto Bio-Pharma Services has never raised funding before.
Ajinomoto Bio-Pharma Services Tech Stack
Discover the technologies and tools that power Ajinomoto Bio-Pharma Services's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
JavaScript libraries
Web servers
JavaScript libraries
Analytics
Web server extensions
Programming languages
Blogs
JavaScript graphics
Analytics
SEO
Frequently asked questions
4.8
40,000 users



